These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15073846)

  • 41. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
    Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
    Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
    Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
    Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
    Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
    Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of Msh2 is not associated with FHIT deletion in breast carcinomas.
    Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(5):2591-5. PubMed ID: 12529969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
    Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
    Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
    Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA
    Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
    Hadaczek P; Siprashvili Z; Markiewski M; Domagala W; Druck T; McCue PA; Pekarsky Y; Ohta M; Huebner K; Lubinski J
    Cancer Res; 1998 Jul; 58(14):2946-51. PubMed ID: 9679951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
    Mori M; Mimori K; Shiraishi T; Alder H; Inoue H; Tanaka Y; Sugimachi K; Huebner K; Croce CM
    Cancer Res; 2000 Mar; 60(5):1177-82. PubMed ID: 10728669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
    Guidi E; Uboldi C; Ferretti L
    Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I; Latil A; Becette V; Lidereau R
    Genes Chromosomes Cancer; 1998 Dec; 23(4):292-9. PubMed ID: 9824201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].
    Wang ZB; Zhao P; Liu M; Li XH
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.